IDEXX LABORATORIES INC /DE is 19.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($43.93 B vs $2.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLDX | IDXX |
|---|---|---|
| Market cap | $2.30 B | $43.93 B |
| US-listed rank | #1998 | #351 |
| Revenue (latest FY) | $1.54M | $4.30B |
| Net income (latest FY) | -$258.76M | $1.06B |
| Net margin | -16748.0% | 24.6% |
| P/E (trailing FY) | - | 41.5 |
| SEC filings | 1,268 | 2,148 |
IDEXX LABORATORIES INC /DE is 19.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($43.93 B vs $2.30 B).
In their latest fiscal years, Celldex Therapeutics, Inc. reported $1.54M in revenue while IDEXX LABORATORIES INC /DE reported $4.30B.
Full pages: Celldex Therapeutics, Inc. and IDEXX LABORATORIES INC /DE, or browse the full rankings.